-
Mashup Score: 6High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE - 3 year(s) ago
(UPDATED) The open-label study had a high crossover rate, throwing some doubt on the reliability of the results, say experts.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1ADAPTABLE: Low-Dose Aspirin as Good as High-Dose in CHD? - 3 year(s) ago
A large randomized trial specifically designed to investigate the optimum dose of aspirin in patients with established coronary disease has found similar efficacy and safety with 81 mg and 325 mg.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
#ACC21: A large randomized trial specifically designed to investigate the optimum dose of aspirin in patients with established coronary disease has found similar efficacy and safety with 81 mg + 325 mg. #ADAPTABLE https://t.co/e93xGSUpt3
-
-
Mashup Score: 1
Original Article from The New England Journal of Medicine — Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease
Source: New England Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet-
RT @DrBenjaminHorne: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease #ADAPTABLE #ACC21 @NEJM https://t.co/5cOhHUeF94
-
-
Mashup Score: 7
Among patients with atherosclerotic CVD, there was no difference in CV events or major bleeding according to aspirin dose, researchers reported at the American College of Cardiology Scientific Session.The open-label, pragmatic, randomized controlled ADAPTABLE trial was the first to use PCORnet, a network established by the Patient-Centered Outcomes Research Institute for comparative effectiveness
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#ADAPTABLE: Among patients with #ASCVD, there was no difference in CV events or major bleeding according to #aspirin dose #ACC21 @ACCmediacenter @ACCinTouch #CardioTwitter @schuyler_jones @DukeHealth @DukeHeartCenter @dmljmd https://t.co/AiLNllxCDM
-
-
Mashup Score: 2ADAPTABLE: Low-Dose Aspirin as Good as High-Dose in CHD? - 3 year(s) ago
A large randomized trial specifically designed to investigate the optimum dose of aspirin in patients with established coronary disease has found similar efficacy and safety with 81 mg and 325 mg.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#ACC21: A large randomized trial specifically designed to investigate the optimum dose of aspirin in patients with established coronary disease has found similar efficacy and safety with 81 mg + 325 mg. https://t.co/DhaoGfvu60 #ADAPTABLE
-
-
Mashup Score: 19Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness - American College of Cardiology - 3 year(s) ago
Anthony A. Bavry, M.D., M.P.H., FACC
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The #ADAPTABLE trial failed to show that aspirin 325 mg was superior to 81 mg in ASCVD patients. More: https://t.co/j5kA2sKB8v #ACC21 @DLBHATTMD @AABavry
-
-
Mashup Score: 2High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE - 3 year(s) ago
The open-label study had a high crossover rate, throwing some doubt on the reliability of the results, say experts.
Source: TCTMD.comCategories: Future of Medicine, Latest HeadlinesTweet-
Late breaking from #ACC21 on #aspirin for coronary artery disease. Trial results showed (with mild caveat) there was NO difference between the 81-mg and 325-mg doses. #ADAPTABLE @ACCinTouch @michaelTCTMD @TCTMD https://t.co/oac0GJnfq6
-
-
Mashup Score: 5ADAPTABLE, with Schuyler Jones, MD, and Manesh Patel, MD - 3 year(s) ago
The first episode of the Heart Trials podcast series focuses on new ACC 2021 research into aspirin dosages for reduced cardiovascular event risk.
Source: HCPLiveCategories: General Medicine News, Latest HeadlinesTweet-
New, for #ACC21: Our new Heart Trials podcast series! The first episode features @schuyler_jones and @manesh_patelMD of @DukeHeartCenter on the new #ADAPTABLE findings, presented today: https://t.co/xCYmdfdLXV
-
-
Mashup Score: 1Science News from ACC.21 - 3 year(s) ago
AHA’s Science News coverage of selected important scientific trials from ACC.21, a virtual conference held May 15-17, 2021.
Source: professional.heart.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#ADAPTABLE results #ACC21: Low-dose aspirin is as effective and safe as a higher dose in secondary prevention of cardiovascular events Read more about ADAPTABLE here: https://t.co/wawK66eeSp
-
-
Mashup Score: 1ADAPTABLE Results - 3 year(s) ago
Erin Michos, MD, MHS, FAHA interviews Schuyler Jones, MD about the results of ADAPTABLE.
Source: YouTubeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Watch more about #ADAPTABLE #ACC21 here https://t.co/Gq02UoHGZG
-
2. Dont forget to get all the news from #ACC21 and expert insight from @TCTMD with #ADAPTABLE https://t.co/819cqpZrYG AND #ATLANTIS https://t.co/5tsp1TI4pf @michaelTCTMD @JSillerMatula @Uqayyum123 @DrAmirKaki @SukhNijjer @rwyeh @MedCrisis @ShrillaB @yourheartdoc1 @nolanjimradial https://t.co/w7XFKqv2VC